KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other Working Capital Changes (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Other Working Capital Changes for 17 consecutive years, with $836.0 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 403.61% to $836.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 62.69% year-over-year, with the annual reading at $1.3 billion for FY2025, 62.69% up from the prior year.
  • Other Working Capital Changes hit $836.0 million in Q4 2025 for Abbott Laboratories, up from -$221.0 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.1 billion in Q1 2023 to a low of -$1.4 billion in Q4 2023.
  • Historically, Other Working Capital Changes has averaged $151.0 million across 5 years, with a median of $131.5 million in 2021.
  • Biggest five-year swings in Other Working Capital Changes: soared 3316.67% in 2022 and later tumbled 4260.61% in 2023.
  • Year by year, Other Working Capital Changes stood at $172.0 million in 2021, then plummeted by 80.81% to $33.0 million in 2022, then crashed by 4260.61% to -$1.4 billion in 2023, then soared by 112.09% to $166.0 million in 2024, then skyrocketed by 403.61% to $836.0 million in 2025.
  • Business Quant data shows Other Working Capital Changes for ABT at $836.0 million in Q4 2025, -$221.0 million in Q3 2025, and $244.0 million in Q2 2025.